THU0097 Neurogenic Inflammation in Rheumatoid Arthritis : Possible Role of Neuropeptides on Synovial Vanilloid Receptors

Background Neurogenic inflammation is caused by neuropeptides, like substance P (SP) and calcitonin gene related peptide (CGRP), which are released by peripheral neurons and induce inflammatory signals. SP and CGRP act through several molecular mechanisms including activation of transient receptor p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2013-06, Vol.72 (Suppl 3), p.A195-A196
Hauptverfasser: Terenzi, R., Romano, E., Guiducci, S., Manetti, M., Galluccio, F., Bandinelli, F., Matucci-Cerinic, M.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A196
container_issue Suppl 3
container_start_page A195
container_title Annals of the rheumatic diseases
container_volume 72
creator Terenzi, R.
Romano, E.
Guiducci, S.
Manetti, M.
Galluccio, F.
Bandinelli, F.
Matucci-Cerinic, M.
description Background Neurogenic inflammation is caused by neuropeptides, like substance P (SP) and calcitonin gene related peptide (CGRP), which are released by peripheral neurons and induce inflammatory signals. SP and CGRP act through several molecular mechanisms including activation of transient receptor potential vanilloid (TRPV) cation channels, particularly TRPV1. SP and CGRP have been found increased in synovial fluid from rheumatoid arthritis (RA) patients and may induce the production of interleukin in RA synoviocytes 1. TRPV cation channels are expressed in various non-neuronal cell types including human synoviocytes 2. Objectives To investigate whether neuropeptides can increase IL-8 production of synoviocytes as pivotal cytokine involved in joint inflammation. To investigate whether SP and CGRP are able to modulate expression of TRPV1 in RA and healthy synoviocytes. Methods RA and healthy synoviocytes were cultured and incubated at 6 hours (SP 10-7M, CGRP10-8M, baseline) and 24 hours (SP 10-7M, CGRP10-8M, SP 10-7M+CAP 10-6M, CGRP 10-8M+CAP 10-6M, baseline). Supernatant of cells incubated 24 hours were assayed by specific ELISA IL-8 Kit. Cells incubated for 6 hours were collected and levels of mRNA of TRPV1 were assayed by Real-Time PCR. Supernatant IL-8 and TRPV1 mRNA are expressed as mean ± standard deviations (SD) and compared by Mann-Whitney Test and t-Student test. The differences are considered significant for p
doi_str_mv 10.1136/annrheumdis-2013-eular.625
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1777913723</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4008723521</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1633-1afbab802c9cbebad7baaf8f83c271569837750c6872023351ac8489823e6303</originalsourceid><addsrcrecordid>eNqVkFFPwyAUhYnRxDn9D0Sfq1BWoHtbFp1GM82cvhLaUmW2MKE16pMv_lF_iXQ1xldfLrnkfOfkHgAOMTrGmNATaYx7VG1daB_FCJNItZV0xzROtsAAjygPvxRtgwFCiESjlLJdsOf9KqyIYz4A78vzO4RS9vXxOVetsw_K6BxemLKSdS0bbQ3UBi66DNlYXcCJax6dbrSHY3hjvddZpeDChmFLuLFYq3WjC-VhYG_fjH3RsoL30uiq6gwWKg8C6_w-2Cll5dXBzzsEy7PT5fQ8urqeXUwnV1GGKSERlmUmM47iPM0zlcmCZVKWvOQkjxlOaMoJYwnKKWcxiglJsMz5iKc8JooSRIbgqLddO_vcKt-IlW2dCYkCM8ZSTFighmDcq3IXjnKqFGuna-neBEaiq1r8qVp0VYtN1SJUHeCoh7Vv1OsvKd2ToIywRMzvp4KepeySxEzMgj7p9Vm9-k_ON8CVmq8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777913723</pqid></control><display><type>article</type><title>THU0097 Neurogenic Inflammation in Rheumatoid Arthritis : Possible Role of Neuropeptides on Synovial Vanilloid Receptors</title><source>BMJ Journals - NESLi2</source><creator>Terenzi, R. ; Romano, E. ; Guiducci, S. ; Manetti, M. ; Galluccio, F. ; Bandinelli, F. ; Matucci-Cerinic, M.</creator><creatorcontrib>Terenzi, R. ; Romano, E. ; Guiducci, S. ; Manetti, M. ; Galluccio, F. ; Bandinelli, F. ; Matucci-Cerinic, M.</creatorcontrib><description>Background Neurogenic inflammation is caused by neuropeptides, like substance P (SP) and calcitonin gene related peptide (CGRP), which are released by peripheral neurons and induce inflammatory signals. SP and CGRP act through several molecular mechanisms including activation of transient receptor potential vanilloid (TRPV) cation channels, particularly TRPV1. SP and CGRP have been found increased in synovial fluid from rheumatoid arthritis (RA) patients and may induce the production of interleukin in RA synoviocytes 1. TRPV cation channels are expressed in various non-neuronal cell types including human synoviocytes 2. Objectives To investigate whether neuropeptides can increase IL-8 production of synoviocytes as pivotal cytokine involved in joint inflammation. To investigate whether SP and CGRP are able to modulate expression of TRPV1 in RA and healthy synoviocytes. Methods RA and healthy synoviocytes were cultured and incubated at 6 hours (SP 10-7M, CGRP10-8M, baseline) and 24 hours (SP 10-7M, CGRP10-8M, SP 10-7M+CAP 10-6M, CGRP 10-8M+CAP 10-6M, baseline). Supernatant of cells incubated 24 hours were assayed by specific ELISA IL-8 Kit. Cells incubated for 6 hours were collected and levels of mRNA of TRPV1 were assayed by Real-Time PCR. Supernatant IL-8 and TRPV1 mRNA are expressed as mean ± standard deviations (SD) and compared by Mann-Whitney Test and t-Student test. The differences are considered significant for p &lt;0,05. Results At baseline IL-8 production of RA synoviocytes was significantly higher than healthy cells (p &lt;0,05)(RA: 2,20±0,17 ng/ml ; healthy: 1,89±0,08 ng/ml). After 24 hours of incubation with neuropeptides RA and healthy synoviocytes did not shown increased IL-8 production. After 24 hours of co-incubation with SP, CGRP and CAP 10-6 IL-8 production of RA synoviocytes was significantly higher than healthy cells and neuropeptides alone (p&lt;0,05) (RA SP10-7M+CAP10-6M=3,07±0,11; healthy SP10-7M+CAP10-6M=1,28±0,12) (RA CGRP 10-8M+CAP10-6M=2,98±0,10; healthy CGRP10-8M+CAP10-6M=1,54±0,46). After 6 hours of incubation with SP and CGRP expression of mRNA TRPV1 was significantly increased (p&lt;0,05) in RA synoviocytes than in healthy cells (healthy SP10-7=0,87 ± 0,27; RA SP10-7=4,00 ± 0,45) ( healthy CGRP 10-8= 0,65 ± 0,05; RA CGRP 10-8=2,61 ± 0,56). Conclusions After co-incubation with SP, CGRP and CAP RA synoviocytes have increased the production of IL-8 suggesting that TRPV1 activation in RA cells may lead to induction of inflammatory stimuli. Levels of TRPV1 mRNA increase in RA synoviocytes after incubation with neuropetides suggesting that SP and CGRP may induce TRPV1 production during disease. In RA neuropeptides may cooperate and activate TRPV1 thus fostering synovial inflammation. References Raap T, Jüsten HP, Miller LE, et al. Neurotransmitter modulation of interleukin 6 (IL-6) and IL-8 secretion of synovial fibroblasts in patients with rheumatoid arthritis compared to osteoarthritis. J Rheumatol 2000;27:2558-65. Kochukov MY, McNearney TA, Fu Y, et al. Thermosensitive TRP ion channels mediate cytosolic calcium response in human synoviocytes. Am J Physiol Cell Physiol 2006;291:424- Disclosure of Interest None Declared</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2013-eular.625</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><ispartof>Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A195-A196</ispartof><rights>2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2013 (c) 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/72/Suppl_3/A195.3.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/72/Suppl_3/A195.3.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3196,23571,27924,27925,77600,77631</link.rule.ids></links><search><creatorcontrib>Terenzi, R.</creatorcontrib><creatorcontrib>Romano, E.</creatorcontrib><creatorcontrib>Guiducci, S.</creatorcontrib><creatorcontrib>Manetti, M.</creatorcontrib><creatorcontrib>Galluccio, F.</creatorcontrib><creatorcontrib>Bandinelli, F.</creatorcontrib><creatorcontrib>Matucci-Cerinic, M.</creatorcontrib><title>THU0097 Neurogenic Inflammation in Rheumatoid Arthritis : Possible Role of Neuropeptides on Synovial Vanilloid Receptors</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><description>Background Neurogenic inflammation is caused by neuropeptides, like substance P (SP) and calcitonin gene related peptide (CGRP), which are released by peripheral neurons and induce inflammatory signals. SP and CGRP act through several molecular mechanisms including activation of transient receptor potential vanilloid (TRPV) cation channels, particularly TRPV1. SP and CGRP have been found increased in synovial fluid from rheumatoid arthritis (RA) patients and may induce the production of interleukin in RA synoviocytes 1. TRPV cation channels are expressed in various non-neuronal cell types including human synoviocytes 2. Objectives To investigate whether neuropeptides can increase IL-8 production of synoviocytes as pivotal cytokine involved in joint inflammation. To investigate whether SP and CGRP are able to modulate expression of TRPV1 in RA and healthy synoviocytes. Methods RA and healthy synoviocytes were cultured and incubated at 6 hours (SP 10-7M, CGRP10-8M, baseline) and 24 hours (SP 10-7M, CGRP10-8M, SP 10-7M+CAP 10-6M, CGRP 10-8M+CAP 10-6M, baseline). Supernatant of cells incubated 24 hours were assayed by specific ELISA IL-8 Kit. Cells incubated for 6 hours were collected and levels of mRNA of TRPV1 were assayed by Real-Time PCR. Supernatant IL-8 and TRPV1 mRNA are expressed as mean ± standard deviations (SD) and compared by Mann-Whitney Test and t-Student test. The differences are considered significant for p &lt;0,05. Results At baseline IL-8 production of RA synoviocytes was significantly higher than healthy cells (p &lt;0,05)(RA: 2,20±0,17 ng/ml ; healthy: 1,89±0,08 ng/ml). After 24 hours of incubation with neuropeptides RA and healthy synoviocytes did not shown increased IL-8 production. After 24 hours of co-incubation with SP, CGRP and CAP 10-6 IL-8 production of RA synoviocytes was significantly higher than healthy cells and neuropeptides alone (p&lt;0,05) (RA SP10-7M+CAP10-6M=3,07±0,11; healthy SP10-7M+CAP10-6M=1,28±0,12) (RA CGRP 10-8M+CAP10-6M=2,98±0,10; healthy CGRP10-8M+CAP10-6M=1,54±0,46). After 6 hours of incubation with SP and CGRP expression of mRNA TRPV1 was significantly increased (p&lt;0,05) in RA synoviocytes than in healthy cells (healthy SP10-7=0,87 ± 0,27; RA SP10-7=4,00 ± 0,45) ( healthy CGRP 10-8= 0,65 ± 0,05; RA CGRP 10-8=2,61 ± 0,56). Conclusions After co-incubation with SP, CGRP and CAP RA synoviocytes have increased the production of IL-8 suggesting that TRPV1 activation in RA cells may lead to induction of inflammatory stimuli. Levels of TRPV1 mRNA increase in RA synoviocytes after incubation with neuropetides suggesting that SP and CGRP may induce TRPV1 production during disease. In RA neuropeptides may cooperate and activate TRPV1 thus fostering synovial inflammation. References Raap T, Jüsten HP, Miller LE, et al. Neurotransmitter modulation of interleukin 6 (IL-6) and IL-8 secretion of synovial fibroblasts in patients with rheumatoid arthritis compared to osteoarthritis. J Rheumatol 2000;27:2558-65. Kochukov MY, McNearney TA, Fu Y, et al. Thermosensitive TRP ion channels mediate cytosolic calcium response in human synoviocytes. Am J Physiol Cell Physiol 2006;291:424- Disclosure of Interest None Declared</description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqVkFFPwyAUhYnRxDn9D0Sfq1BWoHtbFp1GM82cvhLaUmW2MKE16pMv_lF_iXQ1xldfLrnkfOfkHgAOMTrGmNATaYx7VG1daB_FCJNItZV0xzROtsAAjygPvxRtgwFCiESjlLJdsOf9KqyIYz4A78vzO4RS9vXxOVetsw_K6BxemLKSdS0bbQ3UBi66DNlYXcCJax6dbrSHY3hjvddZpeDChmFLuLFYq3WjC-VhYG_fjH3RsoL30uiq6gwWKg8C6_w-2Cll5dXBzzsEy7PT5fQ8urqeXUwnV1GGKSERlmUmM47iPM0zlcmCZVKWvOQkjxlOaMoJYwnKKWcxiglJsMz5iKc8JooSRIbgqLddO_vcKt-IlW2dCYkCM8ZSTFighmDcq3IXjnKqFGuna-neBEaiq1r8qVp0VYtN1SJUHeCoh7Vv1OsvKd2ToIywRMzvp4KepeySxEzMgj7p9Vm9-k_ON8CVmq8</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>Terenzi, R.</creator><creator>Romano, E.</creator><creator>Guiducci, S.</creator><creator>Manetti, M.</creator><creator>Galluccio, F.</creator><creator>Bandinelli, F.</creator><creator>Matucci-Cerinic, M.</creator><general>BMJ Publishing Group Ltd and European League Against Rheumatism</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>201306</creationdate><title>THU0097 Neurogenic Inflammation in Rheumatoid Arthritis : Possible Role of Neuropeptides on Synovial Vanilloid Receptors</title><author>Terenzi, R. ; Romano, E. ; Guiducci, S. ; Manetti, M. ; Galluccio, F. ; Bandinelli, F. ; Matucci-Cerinic, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1633-1afbab802c9cbebad7baaf8f83c271569837750c6872023351ac8489823e6303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Terenzi, R.</creatorcontrib><creatorcontrib>Romano, E.</creatorcontrib><creatorcontrib>Guiducci, S.</creatorcontrib><creatorcontrib>Manetti, M.</creatorcontrib><creatorcontrib>Galluccio, F.</creatorcontrib><creatorcontrib>Bandinelli, F.</creatorcontrib><creatorcontrib>Matucci-Cerinic, M.</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Terenzi, R.</au><au>Romano, E.</au><au>Guiducci, S.</au><au>Manetti, M.</au><au>Galluccio, F.</au><au>Bandinelli, F.</au><au>Matucci-Cerinic, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>THU0097 Neurogenic Inflammation in Rheumatoid Arthritis : Possible Role of Neuropeptides on Synovial Vanilloid Receptors</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2013-06</date><risdate>2013</risdate><volume>72</volume><issue>Suppl 3</issue><spage>A195</spage><epage>A196</epage><pages>A195-A196</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Background Neurogenic inflammation is caused by neuropeptides, like substance P (SP) and calcitonin gene related peptide (CGRP), which are released by peripheral neurons and induce inflammatory signals. SP and CGRP act through several molecular mechanisms including activation of transient receptor potential vanilloid (TRPV) cation channels, particularly TRPV1. SP and CGRP have been found increased in synovial fluid from rheumatoid arthritis (RA) patients and may induce the production of interleukin in RA synoviocytes 1. TRPV cation channels are expressed in various non-neuronal cell types including human synoviocytes 2. Objectives To investigate whether neuropeptides can increase IL-8 production of synoviocytes as pivotal cytokine involved in joint inflammation. To investigate whether SP and CGRP are able to modulate expression of TRPV1 in RA and healthy synoviocytes. Methods RA and healthy synoviocytes were cultured and incubated at 6 hours (SP 10-7M, CGRP10-8M, baseline) and 24 hours (SP 10-7M, CGRP10-8M, SP 10-7M+CAP 10-6M, CGRP 10-8M+CAP 10-6M, baseline). Supernatant of cells incubated 24 hours were assayed by specific ELISA IL-8 Kit. Cells incubated for 6 hours were collected and levels of mRNA of TRPV1 were assayed by Real-Time PCR. Supernatant IL-8 and TRPV1 mRNA are expressed as mean ± standard deviations (SD) and compared by Mann-Whitney Test and t-Student test. The differences are considered significant for p &lt;0,05. Results At baseline IL-8 production of RA synoviocytes was significantly higher than healthy cells (p &lt;0,05)(RA: 2,20±0,17 ng/ml ; healthy: 1,89±0,08 ng/ml). After 24 hours of incubation with neuropeptides RA and healthy synoviocytes did not shown increased IL-8 production. After 24 hours of co-incubation with SP, CGRP and CAP 10-6 IL-8 production of RA synoviocytes was significantly higher than healthy cells and neuropeptides alone (p&lt;0,05) (RA SP10-7M+CAP10-6M=3,07±0,11; healthy SP10-7M+CAP10-6M=1,28±0,12) (RA CGRP 10-8M+CAP10-6M=2,98±0,10; healthy CGRP10-8M+CAP10-6M=1,54±0,46). After 6 hours of incubation with SP and CGRP expression of mRNA TRPV1 was significantly increased (p&lt;0,05) in RA synoviocytes than in healthy cells (healthy SP10-7=0,87 ± 0,27; RA SP10-7=4,00 ± 0,45) ( healthy CGRP 10-8= 0,65 ± 0,05; RA CGRP 10-8=2,61 ± 0,56). Conclusions After co-incubation with SP, CGRP and CAP RA synoviocytes have increased the production of IL-8 suggesting that TRPV1 activation in RA cells may lead to induction of inflammatory stimuli. Levels of TRPV1 mRNA increase in RA synoviocytes after incubation with neuropetides suggesting that SP and CGRP may induce TRPV1 production during disease. In RA neuropeptides may cooperate and activate TRPV1 thus fostering synovial inflammation. References Raap T, Jüsten HP, Miller LE, et al. Neurotransmitter modulation of interleukin 6 (IL-6) and IL-8 secretion of synovial fibroblasts in patients with rheumatoid arthritis compared to osteoarthritis. J Rheumatol 2000;27:2558-65. Kochukov MY, McNearney TA, Fu Y, et al. Thermosensitive TRP ion channels mediate cytosolic calcium response in human synoviocytes. Am J Physiol Cell Physiol 2006;291:424- Disclosure of Interest None Declared</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and European League Against Rheumatism</pub><doi>10.1136/annrheumdis-2013-eular.625</doi></addata></record>
fulltext fulltext
identifier ISSN: 0003-4967
ispartof Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A195-A196
issn 0003-4967
1468-2060
language eng
recordid cdi_proquest_journals_1777913723
source BMJ Journals - NESLi2
title THU0097 Neurogenic Inflammation in Rheumatoid Arthritis : Possible Role of Neuropeptides on Synovial Vanilloid Receptors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T14%3A30%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=THU0097%E2%80%85Neurogenic%20Inflammation%20in%20Rheumatoid%20Arthritis%20:%20Possible%20Role%20of%20Neuropeptides%20on%20Synovial%20Vanilloid%20Receptors&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Terenzi,%20R.&rft.date=2013-06&rft.volume=72&rft.issue=Suppl%203&rft.spage=A195&rft.epage=A196&rft.pages=A195-A196&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/annrheumdis-2013-eular.625&rft_dat=%3Cproquest_cross%3E4008723521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777913723&rft_id=info:pmid/&rfr_iscdi=true